RNAi

Sanofi and Alnylam conclude research phase of RNAi alliance

https://pharmaphorum.com/news/sanofi-and-alnylam-conclude-research-phase-of-rnai-alliance/

Alnylam hopes for 2018 filing for RNAi liver disease drug

https://pharmaphorum.com/news/alnylam-hopes-2018-filing-rnai-liver-disease-drug/

Sanofi passes on Alnylam’s breakthrough therapy

https://pharmaphorum.com/news/sanofi-passes-alnylams-breakthrough-therapy/

Topics Presented this February 2018 at RNA Therapeutics

https://pharmaphorum.com/partner-content-oncology/topics-presented-this-february-2018-at-rna-therapeutics/

Alnylam beats Ionis in RNA drug battle

https://pharmaphorum.com/news/sanofialnylam-improve/

Alnylam soars after drug success, paving way for RNAi era

https://pharmaphorum.com/news/alnylam-shares-jump-rnai-drug-succeeds-rare-disease-trial/

Alnylam a ‘premier league’ addition to UK biotech

https://pharmaphorum.com/news/alnylam-premier-league-addition-uk-biotech/

Coming of age: Alnylam and the RNAi revolution

https://pharmaphorum.com/views-and-analysis/coming-age-alnylam-rnai-revolution/

Alnylam gears up for first RNAi therapeutic filing in 2017

https://pharmaphorum.com/news/alnylam-gears-up-for-first-rnai-therapeutic-filing-in-2017/

Close in 10 seconds

Pharmaphorum.com

Search